SCIEX Announces the 4500MD series* for In Vitro Diagnostic Use
Industry leader increases mass spectrometry portfolio for clinical testing laboratories
July 29, 2014
Framingham, MA — SCIEX, a global leader in analytical technologies, today confirmed its commitment to support the diagnostic market with the unveiling of the Triple Quad™ 4500MD and QTRAP® 4500MD LC/MS/MS systems under its SCIEX Diagnostics brand. Expected to be available in the US and select EU countries in September, the 4500MD series joins the company's growing family of in vitro diagnostic devices, including the 3200MD*, and IVD-MS™ Analyzer* systems launched in 2013, as well as a series of kits* for vitamin D, immunosuppressants and newborn screening testing to be available in August 2014 for use in certain European countries.
The new 4500MD series offers exceptional sensitivity and faster data acquisition over previous systems allowing clinical customers to obtain reliable results so physicians and patients have accurate answers quickly.
The 4500MD series is a flexible LC/MS/MS platform that offers enhanced performance, improved sensitivity and faster data acquisition, to enable customers developing their own applications to validate methods that require lower detection limits or higher throughput, with the peace of mind afforded by a regulatory compliant solution.
"As scientific understanding progressively evolves into improved clinical diagnostic testing, diagnostic customers who develop their own assays are turning to fast, sensitive instruments to perform routine tests with high efficiency and cost savings," said Chris Radloff, Vice President, Applied Markets and Clinical Research at SCIEX. "By bringing the power, flexibility, reliability, and accuracy of our mass spectrometry technology to clinical testing laboratories, SCIEX is enabling customers to deliver high quality diagnostic information to clinicians who make decisions affecting patient care."
SCIEX Diagnostics is focused on delivering high quality technology, service and support to the clinical diagnostics market and is part of SCIEX. Throughout the week at the 2014 AACC Annual Meeting, SCIEX Diagnostics will unveil its latest product at booth #3418. Follow SCIEX at AACC on Twitter with hashtag #ABSCIEXWORLD and #aacc2014.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 25 years of proven innovation, SCIEX focuses on "Answers for Science. Knowledge for life," and excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. Follow SCIEX on Twitter @ABSCIEX and on Facebook and LinkedIn
*Not available in every country. Contact an SCIEX representative or check www.sciexdiagnostics.com for the list of countries. This list will be regularly updated as availability expands.
SCIEX is a part of AB Sciex. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEXTM is being used under license.